IL219769A0 - Drug combination with theromine and its use in therapy - Google Patents

Drug combination with theromine and its use in therapy

Info

Publication number
IL219769A0
IL219769A0 IL219769A IL21976912A IL219769A0 IL 219769 A0 IL219769 A0 IL 219769A0 IL 219769 A IL219769 A IL 219769A IL 21976912 A IL21976912 A IL 21976912A IL 219769 A0 IL219769 A0 IL 219769A0
Authority
IL
Israel
Prior art keywords
theromine
therapy
drug combination
drug
combination
Prior art date
Application number
IL219769A
Original Assignee
Biocopea Ltd
John Brew
Robin Mark Bannister
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd, John Brew, Robin Mark Bannister filed Critical Biocopea Ltd
Publication of IL219769A0 publication Critical patent/IL219769A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL219769A 2009-11-13 2012-05-13 Drug combination with theromine and its use in therapy IL219769A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051896 WO2011058374A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
IL219769A0 true IL219769A0 (en) 2012-07-31

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
IL219769A IL219769A0 (en) 2009-11-13 2012-05-13 Drug combination with theromine and its use in therapy

Country Status (18)

Country Link
EP (1) EP2498776A1 (en)
JP (2) JP2013510842A (en)
CN (1) CN102740853B (en)
AU (1) AU2010317668C1 (en)
BR (1) BR112012011224A2 (en)
CA (1) CA2780704C (en)
CO (1) CO6551745A2 (en)
EC (2) ECSP12011893A (en)
GB (1) GB0919893D0 (en)
IL (1) IL219769A0 (en)
MX (1) MX2012005538A (en)
NZ (1) NZ599957A (en)
PE (1) PE20121472A1 (en)
RU (1) RU2587329C2 (en)
SG (1) SG10201407496SA (en)
UA (1) UA105940C2 (en)
WO (1) WO2011058374A1 (en)
ZA (1) ZA201204247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850568D1 (en) * 1987-10-08 1994-08-11 Andor Bilas FABRIC MIXTURE TO STABILIZE THE METABOLISM LOCATION.
JPH09502201A (en) * 1993-09-07 1997-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー Composition containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant, expectorant, antihistamine and antitussive agent
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
AU2002356962C1 (en) * 2001-12-12 2008-05-01 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
DK1603533T3 (en) * 2003-02-28 2009-08-17 Ym Biosciences Inc Opioid delivery system
CN1593451A (en) * 2003-09-12 2005-03-16 杨喜鸿 Externally applied medicine for promoting male erection
WO2006064780A1 (en) * 2004-12-14 2006-06-22 Shionogi & Co., Ltd. Therapeutic agent for constipation
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Compositions for treating of cough

Also Published As

Publication number Publication date
EP2498776A1 (en) 2012-09-19
AU2010317668C1 (en) 2016-02-11
ZA201204247B (en) 2013-02-27
NZ599957A (en) 2014-05-30
PE20121472A1 (en) 2012-11-30
CN102740853A (en) 2012-10-17
JP2013510842A (en) 2013-03-28
GB0919893D0 (en) 2009-12-30
AU2010317668A1 (en) 2012-06-07
AU2010317668B2 (en) 2015-01-22
ECSP12011892A (en) 2012-09-28
CO6551745A2 (en) 2012-10-31
BR112012011224A2 (en) 2017-03-01
JP2016041748A (en) 2016-03-31
CN102740853B (en) 2015-04-08
CA2780704A1 (en) 2011-05-19
SG10201407496SA (en) 2015-02-27
RU2587329C2 (en) 2016-06-20
UA105940C2 (en) 2014-07-10
RU2012124063A (en) 2013-12-20
WO2011058374A1 (en) 2011-05-19
MX2012005538A (en) 2012-09-28
CA2780704C (en) 2018-07-17
ECSP12011893A (en) 2012-10-30

Similar Documents

Publication Publication Date Title
IL222006A (en) Conjugates of pyrrolobenzodiazepines and their use in therapy
HK1221478A1 (en) Sap variants and their use sap
IL214244A0 (en) Scriptaid isosteres and their use in therapy
EP2579865A4 (en) Combination therapy with lisdexamphetamine and extended release guanfacine
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB0921803D0 (en) Drug composition and its use in therapy
IL209361A0 (en) Combination therapy with pm00104 and another antitumor agent
IL219768A0 (en) Drug combination with thebromine and its use in therapy
HK1168283A1 (en) Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto sorcs1
GB2460178B (en) Depsipeptides and their therapeutic use
IL219769A0 (en) Drug combination with theromine and its use in therapy
GB2460181B (en) Depsipeptides and their therapeutic use
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
HK1182397A1 (en) New octapeptide compounds and their use in therapy
GB2460180B (en) Depsipeptides and their therapeutic use
GB0920267D0 (en) Drug combination and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0918727D0 (en) Drug composition and its use in therapy
GB0909354D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0909344D0 (en) Drug composition and its uses in therapy